SCHEMBL6862984

SCHEMBL6862984

O=C1Nc2cc(Br)ccc2/C1=C/c1c[nH]c2ncccc12

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 5/20 0.73
CHEK2 O96017 1/20 0.63
CDK1 P06493 1/20 0.63
SRC P12931 1/20 0.63
CSNK2A2 P19784 1/20 0.63
CSNK2B P67870 1/20 0.63
CSNK2A1 P68400 1/20 0.63
HASPIN Q8TF76 4/20 0.49
TGM2 P21980 1/20 0.49
NTRK1 P04629 4/20 0.48
KDR P35968 3/20 0.48
PRKD3 O94806 2/20 0.48
ABL1 P00519 2/20 0.48
RET P07949 2/20 0.48
PDGFRB P09619 2/20 0.48
LTK P29376 2/20 0.48
FLT3 P36888 2/20 0.48
CSNK1A1 P48729 2/20 0.48
CDK7 P50613 2/20 0.48
MAP2K1 Q02750 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6862990 1.00 CHEK1 (0.73) CHEK1CHEK2CDK1SRCCSNK2A2
SCHEMBL857064 0.85 CHEK1 (1.00) CHEK1CHEK2CDK1SRCCSNK2A2
SCHEMBL8464117 0.85 CHEK1 (1.00) CHEK1CHEK2CDK1SRCCSNK2A2
SCHEMBL8464120 0.85 CHEK1 (1.00) CHEK1CHEK2CDK1SRCCSNK2A2
SCHEMBL5465283 0.81 NTRK1 (0.73) CHEK1NTRK1KDRPRKD3ABL1
SCHEMBL6861663 0.81 NTRK1 (0.73) CHEK1NTRK1KDRPRKD3ABL1
SCHEMBL5465281 0.81 NTRK1 (0.73) CHEK1NTRK1KDRPRKD3ABL1
SCHEMBL8467707 0.80 CHEK1 (0.73) CHEK1CHEK2CDK1SRCCSNK2A2
SCHEMBL8467705 0.80 CHEK1 (0.73) CHEK1CHEK2CDK1SRCCSNK2A2
SCHEMBL6288777 0.79 CHEK1 (0.76) CHEK1CHEK2CDK1SRCCSNK2A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6797825-B2 1,3-DIHYDRO-2H-INDOL- 2-ONE DERIVATIVES ABBOTT LABORATORIES 2004-09-28 US disclosed
US-20030162785-A1 Protein kinase inhibitors ABBVIE INC. 2003-08-28 US disclosed
US-20030119839-A1 Protein kinase inhibitors ABBOTT LABORATORIES 2003-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162785-A1 Protein kinase inhibitors MAP3K20, MAP3K1, MAP3K6 CHEK1 139/4885CHEK2 93/4885CDK1 62/4885
US-20030119839-A1 Protein kinase inhibitors MAP3K20, MAP3K1, MAP3K6 CHEK1 139/4885CHEK2 93/4885CDK1 62/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.